Bill Text: NY A09013 | 2019-2020 | General Assembly | Amended


Bill Title: Authorizes pharmacists to dispense HIV pre-exposure and post-exposure prophylaxis.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Introduced - Dead) 2020-06-17 - print number 9013a [A09013 Detail]

Download: New_York-2019-A09013-Amended.html



                STATE OF NEW YORK
        ________________________________________________________________________

                                         9013--A

                   IN ASSEMBLY

                                    January 10, 2020
                                       ___________

        Introduced  by  M. of A. BARRETT, GOTTFRIED -- read once and referred to
          the Committee  on  Higher  Education  --  committee  discharged,  bill
          amended,  ordered reprinted as amended and recommitted to said commit-
          tee

        AN ACT to amend the education law, in relation  to  authorizing  pharma-
          cists to dispense HIV pre-exposure and post-exposure prophylaxis

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subdivision 7-a of section 6527 of the  education  law,  as
     2  added by chapter 502 of the laws of 2016, is amended to read as follows:
     3    7-a.  A  licensed physician may prescribe and order a patient specific
     4  order or non-patient specific order to a licensed  pharmacist,  pursuant
     5  to  regulations promulgated by the commissioner in consultation with the
     6  commissioner of health, and consistent with the public health  law,  for
     7  dispensing  up  to a seven day starter pack of HIV post-exposure prophy-
     8  laxis  for  the  purpose  of  preventing  human  immunodeficiency  virus
     9  infection following a potential human immunodeficiency virus exposure. A
    10  licensed  physician  may  also prescribe and order a patient specific or
    11  non-patient specific order to a licensed pharmacist, pursuant  to  regu-
    12  lations promulgated by the commissioner in consultation with the commis-
    13  sioner  of health, and consistent with the public health law and section
    14  sixty-eight hundred one of this title, for HIV pre-exposure prophylaxis,
    15  provided, however, that the regulations  promulgated  pursuant  to  this
    16  subdivision  shall require that the HIV pre-exposure prophylaxis author-
    17  ized to be dispensed by a licensed pharmacist shall provide for at least
    18  a thirty-day, but no more than a sixty-day, supply of such prophylaxis.
    19    § 2. Subdivision 8 of section 6909 of the education law, as  added  by
    20  chapter 502 of the laws of 2016, is amended to read as follows:
    21    8.  A  certified  nurse practitioner may prescribe and order a patient
    22  specific order or non-patient specific order to a  licensed  pharmacist,
    23  pursuant  to regulations promulgated by the commissioner in consultation
    24  with the commissioner of health, and consistent with the  public  health
    25  law,  for dispensing up to a seven day starter pack of HIV post-exposure
    26  prophylaxis for the purpose of preventing human  immunodeficiency  virus

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD14442-06-0

        A. 9013--A                          2

     1  infection following a potential human immunodeficiency virus exposure. A
     2  certified  nurse  practitioner  may  also  prescribe and order a patient
     3  specific or non-patient specific order to a licensed pharmacist,  pursu-
     4  ant  to regulations promulgated by the commissioner in consultation with
     5  the commissioner of health, and consistent with the  public  health  law
     6  and  section sixty-eight hundred one of this title, for HIV pre-exposure
     7  prophylaxis, provided, however, that the regulations promulgated  pursu-
     8  ant  to this subdivision shall require that the HIV pre-exposure prophy-
     9  laxis authorized to be dispensed by a licensed pharmacist shall  provide
    10  for  at least a thirty-day, but no more than a sixty-day, supply of such
    11  prophylaxis.
    12    § 3. Subdivision 5 of section 6801 of the education law, as  added  by
    13  chapter  502  of the laws of 2016, is amended and a new subdivision 6 is
    14  added to read as follows:
    15    5. A licensed pharmacist may execute a non-patient specific order, for
    16  dispensing up to a seven day starter pack of HIV  post-exposure  prophy-
    17  laxis  medications  for the purpose of preventing human immunodeficiency
    18  virus infection, by a physician licensed in this state or nurse  practi-
    19  tioner  certified  in  this  state,  pursuant  to  rules and regulations
    20  promulgated by the commissioner in consultation with the commissioner of
    21  health following a potential human immunodeficiency virus exposure.  The
    22  pharmacist  shall also inform the patient of the availability of pre-ex-
    23  posure prophylaxis for persons who are at substantial risk of  acquiring
    24  HIV.
    25    6. A licensed pharmacist may execute a non-patient specific order, for
    26  dispensing  HIV  pre-exposure  prophylaxis,  pursuant to rules and regu-
    27  lations promulgated by the commissioner in consultation with the commis-
    28  sioner of health provided,  however,  that  the  rules  and  regulations
    29  promulgated  pursuant  to  this  subdivision  shall require that the HIV
    30  pre-exposure prophylaxis authorized to be dispensed by a licensed  phar-
    31  macist  shall  provide  for  at  least  a thirty-day, but no more than a
    32  sixty-day, supply of such prophylaxis. And provided, further,  that  the
    33  following  conditions shall be met before a pharmacist may dispense pre-
    34  exposure prophylaxis:
    35    (a) The pharmacist has completed a training  program  created  by  the
    36  department  of health on the use of pre-exposure prophylaxis. The train-
    37  ing program shall educate pharmacists about  the  requirements  of  this
    38  subdivision,  the  risks  and  side  effects  of the medication, patient
    39  insurance and cost burdens, and any other  information  such  department
    40  deems necessary or important;
    41    (b)  The patient is HIV negative, as documented by a negative HIV test
    42  result  obtained  within  the  previous   seven   days   from   an   HIV
    43  antigen/antibody  test  or antibody-only test or from a rapid, point-of-
    44  care fingerstick blood test approved by the federal food and drug admin-
    45  istration. If the patient does not provide evidence of  a  negative  HIV
    46  test  in accordance with this paragraph, the pharmacist may recommend an
    47  HIV test. If the patient tests positive for HIV infection,  the  pharma-
    48  cist  shall  direct  the patient to a licensed physician and provide the
    49  patient with a list of health care service providers and clinics  within
    50  the county where the pharmacist is located or adjacent counties;
    51    (c)  The  patient  does  not report any signs or symptoms of acute HIV
    52  infection on a self-reported checklist of acute HIV infection signs  and
    53  symptoms;
    54    (d)  The  patient  does  not report taking any contraindicated medica-
    55  tions;

        A. 9013--A                          3

     1    (e) The pharmacist does not furnish more than a  sixty-day  supply  of
     2  pre-exposure  prophylaxis  to  a single patient more than once every two
     3  years, unless directed otherwise by a prescriber.
     4    (f)  The  pharmacist  provides  written  information, published by the
     5  department of health, to the patient on the ongoing use of  pre-exposure
     6  prophylaxis,  which  may  include  education  about side effects, safety
     7  during pregnancy and breastfeeding, adherence to recommended dosing, and
     8  the importance of timely testing and treatment, as applicable, for  HIV,
     9  renal function, hepatitis B, hepatitis C, sexually transmitted diseases,
    10  and  pregnancy for individuals of child-bearing capacity. The pharmacist
    11  shall notify the patient that the patient must be  seen  by  a  licensed
    12  physician  to  receive subsequent prescriptions for pre-exposure prophy-
    13  laxis; and
    14    (g) The pharmacist provides information, with the  patient's  consent,
    15  to  the patient or, when the patient lacks capacity to consent, a person
    16  authorized to consent to health care for such individual, on the  impor-
    17  tance of having a health care provider, developed by the commissioner of
    18  health,  and  if  the  patient  does not have a health care provider the
    19  pharmacist shall provide the patient  a  list  of  licensed  physicians,
    20  clinics,  or other health care service providers within the county where
    21  the pharmacist is located or adjacent counties.
    22    § 4. This act shall take effect on the one hundred eightieth day after
    23  it shall have become a law; provided, however, the amendments to section
    24  6801 of the education law made by section three of this  act  shall  not
    25  affect  the  expiration  of  such  section and shall be deemed to expire
    26  therewith. Effective  immediately,  the  commissioner  of  education  is
    27  authorized  to promulgate any and all rules and regulations and take any
    28  other measures necessary to implement this act on or before such  effec-
    29  tive date.
feedback